Transgenic over-expression of the microRNA miR-17-92 cluster promotes proliferation and inhibits differentiation of lung epithelial progenitor cells  by Lu, Yun et al.
Developmental Biology 310 (2007) 442–453
www.elsevier.com/developmentalbiologyGenomes & Developmental Control
Transgenic over-expression of the microRNA miR-17-92 cluster promotes
proliferation and inhibits differentiation of lung epithelial progenitor cells
Yun Lu a, J. Michael Thomson b, Ho Yuen Frank Wong a,
Scott M. Hammond b,c, Brigid L.M. Hogan a,⁎
a Department of Cell Biology, Duke University Medical Center, Durham, NC 27710, USA
b Department of Cell and Developmental Biology, University of North Carolina, Chapel Hill, NC 27599, USA
c Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27599, USA
Received for publication 5 June 2007; revised 30 July 2007; accepted 1 August 2007
Available online 9 August 2007Abstract
The miR-17-92 locus encodes a cluster of 7 microRNAs transcribed as a single primary transcript. It can accelerate c-Myc induced B cell
lymphoma development and is highly expressed in many tumors, including lung tumors. However, the role of miR-17-92 in development has not
been well studied. From analysis of microRNAs during lung development, expression of the miR-17-92 cluster is high at early stages, but declines as
development proceeds. We used the mouse surfactant protein C (Sftpc) promoter to over-express the cluster in embryonic lung epithelium.
Transgenic lungs have a very abnormal lethal phenotype. They contain numerous proliferative epithelial cells that retain high levels of Sox9, a marker
of distal progenitors. The differentiation of proximal epithelial cells was also inhibited. Furthermore, a significant increase in the number of
neuroendocrine cell clusters was observed in the lungs of dead transgenic pups.We identify a tumor suppressor, Rbl2 which belongs to the Rb family,
as a new target for miR-17-5p. Together, these studies suggest that mir-17-92 normally promotes the high proliferation and undifferentiated
phenotype of lung epithelial progenitor cells.
© 2007 Elsevier Inc. All rights reserved.Keywords: miR-17-92; miRNAs; Lung development; Rbl2; Proliferation; Progenitor epithelial cellsIntroduction
MicroRNAs (miRNAs) are a class of small (∼22 bp), non-
coding RNAs that regulate gene expression at a post transcrip-
tional level. They are first transcribed as primary miRNAs by
RNA polymerase II (Cai et al., 2004) and then cut by the RNase-
III enzyme, Drosha, into ∼70-nucleotide precursors (pre-
miRNAs) (Lee et al., 2002, 2003), which are transported to the
cytoplasm by Exportin 5 (Zeng and Cullen, 2004). Another
enzyme, Dicer, then processes the pre-miRNAs to mature
miRNAs (Bernstein et al., 2001; Hutvagner et al., 2001), which
are recruited into the RNA-induced silencing complex (RISC)
(Khvorova et al., 2003; Schwarz et al., 2003). Finally, this⁎ Corresponding author. Fax: +1 919 684 8592.
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doi:10.1016/j.ydbio.2007.08.007complex interferes with the translation and stability of target
messenger RNAs (He and Hannon, 2004).
It is clear that miRNAs play an important role in develop-
ment. Loss of Dicer, which completely blocks the processing of
all miRNAs, causes embryonic lethality in both zebra fish
(Giraldez et al., 2005) and mice (Bernstein et al., 2003). Hair
follicle growth (Andl et al., 2006), skin morphogenesis (Yi et
al., 2006) and angiogenesis (Yang et al., 2005) are also affected
by deficiency of Dicer. Recently, it was reported that con-
ditional deletion of Dicer in embryonic lung epithelium leads to
inhibition of branching and increased apoptosis (Harris et al.,
2006) suggesting that miRNAs play an important role in lung
development. However, only a few miRNAs have been well
studied for their function in mammalian development. For
example, it was suggested that miR-1, regulated by serum
response factors, controls the balance between differentiation
and proliferation during cardiogenesis and muscle development
443Y. Lu et al. / Developmental Biology 310 (2007) 442–453by targeting Hand2 and HDAC4, respectively (Chen et al.,
2006; Zhao et al., 2005, 2007).
Here, we explore the function of a miRNA cluster, miR-17-
92, in mouse lung development.MiR-17-92 is a conserved gene
which encodes 7 miRNAs. It also has two homologous miRNA
clusters in the mouse genome (Fig. 1A). The human gene is
located at chromosome 13q31, in the intron of chr13orf25.
Amplification of this region has been reported in follicular
lymphoma, B-cell lymphoma and in several lung and head and
neck carcinomas (Knuutila et al., 1998). Recently, a large-scale
analysis of the miRNA profiles of solid tumors showed up-
regulation of the human miR-17-92 cluster in many cancers,
including lung cancer (Volinia et al., 2006) and small-cell lung
cancer that is thought to arise from neuroendocrine cells
(Hayashita et al., 2005). In addition to its upregulation in cancer
cells recent studies showed that miR-17-92 is highly expressed
in embryonic stem cells, with expression levels decreasing
during embryonic development in mice (Thomson et al., 2004).
This is consistent with miRNA cloning data from pluripotential
mouse embryonic stem (ES) cells (Houbaviy et al., 2003). Taken
together, these results support the idea that high level ofmiR-17-Fig. 1. Relative expression of miR-17-92 cluster members during lung
development. (A) Genomic organization of three homologous mouse miRNA
clusters (miR-17-92, miR106a-363 and miR-106b-25) (yellow boxes, pre-
miRNAs; blue boxes, mature miRNAs). Note that miR-18X is a predicted
miRNA, which has not yet been cloned. MicroRNA microarray (B) and
Northern blot (C) show the relative expression levels of miR-17-92 cluster
members in developing lungs. Five different developmental stages are shown:
E11.5, E13.5, E15.5, E17.5 and adult (about 12 weeks old).92 promote the proliferation of progenitor cells and inhibit their
differentiation. However, little is known about the role of miR-
17-92 in the development of specific organs, including the lung.
In the mouse, lung development begins around embryonic
days 9.5 (E9.5) when two primordial buds of epithelial
endoderm cells surrounded by mesoderm grow out of the
ventral foregut (Cardoso and Lu, 2006). Subsequent lung
development can be divided into four stages, termed pseudo-
glandular, canalicular, terminal sac and alveolar. During the first
two stages the distal tips of the lung buds contain a population of
highly proliferative cuboidal epithelial cells. Descendants of
these cells populate the more proximal tubules as the buds
elongate. Beginning around E14, the proximal cells begin to
differentiate into Clara, ciliated and neuroendocrine cells.
During the saccular stage the distal epithelial cells give rise to
the progenitors of the primitive alveoli which subsequently
differentiate into specialized type I and type II cells. At the
beginning of this study, we found that miR-17-92 is highly
expressed in the E11.5 lung and its level declines as development
proceeds. We therefore hypothesized that miR-17-92 is impor-
tant for maintaining lung progenitor cells. In this study, we over-
expressed the whole miR-17-92 cluster in the distal epithelium
of transgenic lungs from around E10.5, using the mouse sur-
factant protein C promoter. This results in a very abnormal lung
phenotype, in particular the accumulation of large numbers of
highly proliferative epithelial cells expressing markers of pro-
genitors. In a search for potential targets ofmiR-17-5p that could
account for this phenotype we have identified the tumor sup-
pressor Rbl2. How this target may contribute to the network of
genes potentially regulated by the cluster during lung develop-
ment is discussed.
Materials and methods
Mice
A schematic diagram of the transgenic construct is shown in Fig. 3A. The
mouse 6.5 kb Sftpc promoter was kindly provided by Edward Morrisey,
University of Pennsylvania. It drives transgene expression in the distal lung
epithelium from about E10.5 (personal communication). The mouse 1.1 kbmiR-
17-92 cluster DNA was cloned by PCR from C57BL/6 mouse genomic DNA,
using primer sets: sense, 5′ GTCAGAATTCCCCCTTGGGTATAAGCTG-
TAATT; anti-sense, 5′ GTCACTCGAGACCAACGAAAGCAATAGAAATCA
(Restriction sites, EcoRI and XhoI, were added for cloning). The 0.4 kb SV40
small T intron and poly A were derived from plasmid pKC4 by HindIII and
BamHI. A total of 8 transgenic embryos at E18.5 and 2 transgenic mice were
generated by pronuclear injection of fertilized eggs of the FVB inbred strain at the
Duke Transgenic Mouse Facility. Transgenic adults were crossed with ICR mice
to obtain transgenic pups at P0.
MicroRNA in situ hybridization
Protocols for section and whole mount in situ hybridization were obtained
from Exiqon (http://www.exiqon.com). Briefly, paraffin wax-embedded sections
were dewaxed, pretreated with proteinase K (10 min at RT) and hybridized with
Locked Nucleic Acid (LNA) probes (pre-designed oligos from Exiqon) in 50%
formamide hybridization mix at 49 °C. Probes were labeled with Digoxigenin
(DIG) using DIG oligonucleotide 3′-end labeling kit, 2nd generation (Roche).
Slides were then washed with 2× SSC and 2× SSC plus 50% formamide at 49 °C.
The DIG-labeled probes were detected by alkaline phosphatase-coupled anti-
DIG (Roche), followed by color development (Substrate: NBT, BCIP, Promega).
Table 1
miR E11.5 E17.5
17-5p 2.2% 1.9%
18 2.0% 1.1%
19a 0.1% 0.1%
19b 1.1% 0.1%
20 3.5% 0.7%
92 1.6% 0.7%
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proteinase K treatment for E11.5 embryos and E12.5 lungs was 30 and 10 min,
respectively, at 37 °C. The antibody wash for E11.5 embryos and E12.5 lungs
was 3 days and 6 h respectively at 4 °C.
RNA extraction and Northern blot
Lungs were collected and immediately frozen in liquid nitrogen and stored at
−80 °C. RNAwas extracted by Trizol (Invitrogen) following the product manual.
The Northern blot protocol was derived from Exiqon (http://www.exiqon.com).
Briefly, total RNA was separated by 15% polyacrylamide gel electrophoresis
with 0.5× TBE. After 1.5 h transfer to a Hybond-N+ nylon membrane
(Amersham) by semi-dry transfer cell (Bio-Rad), the membrane was prehy-
bridized and hybridized in PerfectHyb Plus Hybridization Buffer (Sigma) at
49 °C for LNA probes or room temperature (RT) for DNA probes. Probes were
labeled with 32P γ-ATP by T4 Polynucleotide Kinase (New England BioLabs).
The membrane was washed with 10× SSC at RT for autoradiography.
MiRNA microarray and Affymetrix analysis
MiRNA microarray was performed essentially as described (Thomson et al.,
2004). For the Affymetrix analysis, total RNA (10 μg) was extracted from three
normal and three transgenic lungs using Trizol (Invitrogen) and RNeasyMini Kit
(Qiagen) and assessed for quality with an Agilent Labon-a-Chip 2100 Bio-
analyzer (Agilent Technologies). All the reactions were carried out at Duke
Microarray Facility. In brief, probes for hybridization were prepared from total
RNA according to standard Affymetrix protocols. First strand cDNA was syn-
thesized using a T7-linked oligo-dT primer, followed by second strand synthesis.
An in vitro transcription reaction was performed to generate the cRNA con-
taining biotinylated UTP and CTP, which was subsequently fragmented chemi-
cally at 95 °C for 35 min. The fragmented, biotinylated cRNAwas hybridized in
MES buffer (2-[N-morpholino]ethanesulfonic acid) containing 0.5 mg/ml
acetylated bovine serum albumin to Affymetrix GeneChip Mouse 430A arrays
at 45 °C for 16 h, according to the Affymetrix protocol (http://www.affymetrix.
com). Arrays were washed and stained with streptavidin–phycoerythrin (SAPE;
Molecular Probes Inc, Eugene, USA). Signal amplification was performed using
a biotinylated anti-streptavidin antibody (Vector Laboratories) at 3 μg/ml. This
was followed by a second staining with SAPE. Normal goat IgG (2 mg/ml) was
used as a blocking agent. All data are available in Figure S1 and Table S1.
MiRNA cloning
The miRNA cloning was performed as described (Lau et al., 2001), except
that the 50 μg total RNA extracted by Trizol from lung samples was first enriched
for the small RNA fraction by mirVana miRNA Isolation Kit (Ambion) before
cloning.
Immunohistochemistry
Tissues for immunohistochemistry were fixed in 4% freshly prepared
paraformaldehyde in PBS at 4 °C overnight, embedded in paraffin wax and
sectioned at 7 μm. After rehydration, the endogenous enzyme activity was
quenched by 2% H2O2 in methanol (30 min). Before the blocking and antibody
reaction in 2% BSA, 5% serum and 0.1% Triton X-100 in PBS, different antigen
retrievals were performed for different antibodies, as follows: Mouse anti-BrdU
(Sigma, 1:500): 2 N HCl at 37 °C, 20 min and then 0.05% trypsin/PBS at room
temperature (RT), 5 min; rabbit anti-proSurfactant protein C (Chemicon, 1:200):
0.05% trypsin/PBS at RT, 5 min; mouse anti-Nkx2.1 (NeoMakers, 1:500):
microwave antigen retrieval with 10mMpH6.0 sodium citrate. Rabbit anti-CC10
(kindly provided by Barry Stripp, 1:10,000), goat anti-Scgbla1 (CCSP/CC10)
(kindly provided by Barry Stripp, 1:10,000), mouse anti-β tubulin (BioGenex,
1:1000), rabbit anti-CGRP (Penlabs, 1:1000), rabbit anti-Sox9 (kindly provided
by Dr. Francis Poulat, 1:2000), rabbit anti-Nmyc (SantaCruz, 1:100) and rabbit
anti-Rbl2/p130 (Abcam, 1:500) did not need antigen retrieval. Secondary
antibodies for the color reactionswere purchased from Jackson ImmunoResearch
and Molecular Probes. Signal was amplified by ABC kit (Vector) and color was
developed by peroxidase substrate kit DAB (Vector).Luciferase assay
A schematic diagram of the luciferase reporter construct is shown in Fig. 7A.
The firefly luciferase gene, derived from pGL3-Basic vector (Promega), was
cloned into pcDNA3.1(+) by HindIII and EcoRI. Rbl2 3′UTR fragment was
cloned by PCR from C57BL/6 mouse genomic DNA and inserted into
pcDNA3.1(+) behind firefly luciferase using EcoRI and XhoI. The primer sets
for cloning are: sense, 5′ AGTCGAATTCTCTTCCTCTACTTAGTGCTTAC;
anti-sense, 5′ AGTCCTCGAGGATAGTTTCTTTGGGATAACTAC. The point
mutation procedure followed the instruction manual of QuickChange II Site-
Directed Mutagenesis Kit (Stratagene). The primer sets for point mutations are:
site 1 sense: 5′ AAGGAACCTGTGTAATTGGTGGGTGTTTATGGCTGTAA-
GATGCATAG; site 1 anti-sense: 5′ CTATGCATCTTACAGCCATAAACACC-
CACCAATTACACAGGTTCCTT; site 2 sense: 5′ GGGTTTGCTGTATATT-
TATGATGGGTGTTTCTATGGTGTGAACTTTGGTAG; site 2 anti-sense: 5′
CTACCAAAGTTCACACCATAGAAACACCCATCATAAATATACAG-
CAAACCC. 3×104 Hela cells were seeded per well in 24-well plate the day
before transfection and then cells were transfected with 50 ng firefly luciferase
reporter vector, 50 ng Renilla luciferase control vector pRL-SV40 (Promega)
and 15 pmol Pre-miR miRNA Precursor Molecules (Ambion) per well by
Lipofectamine 2000 (Invitrogen). 24 h after transfection, luciferase signal was
detected by Dual-Luciferase Reporter Assay System (Promega).Results
The miR-17-92 cluster is expressed in both the endoderm and
mesoderm of the developing lung
To determine which miRNAs are expressed in the developing
lung, we carried out miRNA microarray analysis of total RNA
from lungs of different embryonic stages and the adult (Figure
S1). We found that about 37% (73/198) of miRNAs have no or
very low expression at any stage. By contrast, 36% (72/198) and
11% (22/198) of miRNAs have highest expression in the adult or
early embryonic (E11.5) lung, respectively. Of the remainder, 11
show a peak at E17.5, the end of the canalicular stage, and the
others show either two peaks of expression or little change
during lung development.
The subclass of miRNAs shown by microarray analysis to be
expressed at highest levels during early development included 6
members of the miR-17-92 cluster (Fig. 1B). This result was
confirmed by Northern blot analysis (Fig. 1C). We also carried
out miRNA cloning from small RNA extracted from lungs at
E11.5 and E17.5. We found that more than 10% of the total
small RNA clones come from the miR-17-92 cluster at E11.5
(Table 1). Five members of the cluster, miR-17-5p, miR-18,
miR-19b, miR-20a and miR-92, have relatively high abundance,
while miR-19a has very low abundance and miR-17-3p is not
represented at all. As expected, the abundance of all six
miRNAs decreases at E17.5, but the fold decrease differs among
the cluster members. For example, miR-19b decreases 11 fold in
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Another homologous miRNA cluster, miR-106a-363 which
also contains miR-19b and miR-92 (Fig. 1A), exists on chro-
mosome X. However, no clone of miR-106a, miR-18X, miR-
20b and miR-363 was found at E11.5 or E17.5, suggesting that
this cluster is not active in the lung.
In situ hybridization with LNA probes to three members of
the cluster, miR-17-5p, miR-19b and miR-20 supports the
conclusion that the gene is widely, but not uniformly expressed
in the E11.5 embryo (Figs. 2A–C). All three miRNAs have high
expression levels in the central and peripheral nervous system
and dorsal root ganglia, somite mesoderm and in many internal
organs, including the lung, intestine, and stomach. However, the
liver has only very weak expression (Fig. 2H). In the E11.5 and
E12.5 lungs, the three members are expressed in both the
endoderm and mesoderm (Figs. 2C–G, I–L). In the endodermalFig. 2. MiR-17-92 expression in embryos and lungs. (A, B) E11.5 mouse embryos.
hybridization of miR-17-5p, miR-19b and miR-20 were performed using LNA probe
regions boxed in panels C, E and H respectively. The negative control for in situ hybr
Scale bar=50 μm.epithelial cells, the miRNAs appear to locate most strongly to the
apical cytoplasm (Figs. 2F, I, K).
Abnormal lung development in miR-17-92 transgenic embryos
and new born pups
To test the function of miR-17-92 in lung development, we
over-expressed the whole cluster in the lung epithelium of
transgenic embryos using the mouse surfactant protein C pro-
moter (Fig. 3A). In total, 10 transgenic founders were obtained,
which were Sftpc-miR-17-92 positive by PCR. Of these, 8 were
collected at E18.5 and 5 of them showed an obvious
hypercellularity phenotype in the lung (Figs. 3C, E). The 3
that showed no phenotype did not express the transgene, as
judged by microRNA microarray analysis (Figure S2). Two
female founders survived and were crossed with wild type(C, D) E12.5 lungs. (E–L) Cross section of E11.5 embryos and lungs. In situ
s (whole mount: A–D; paraffin section: E–L). (D, F, I) High magnification of
idization was done without the probes. (C–E, H) Scale bar=200 μm; (F, G, I–L)
Fig. 3. Abnormal lung phenotype observed in miR-17-92 cluster transgenic embryos and newborn pups. (A) Schematic illustration of miR-17-92 cluster transgenic
construct. The cluster contains all six miRNA precursors and 133 bp genomic flanking region at both ends. (B–I) H&E stained sections of left lobe from both the
normal and transgenic lungs. (D, E, H, I) The enlarged pictures of panels B, C, F and G respectively. (J, K) MiR-17-5p in situ hybridization of normal and transgenic P0
lungs. (L) Microarray analysis shows that the expression levels of all six miRNAs within the cluster are increased in the transgenic lungs. Tested RNAwas extracted
from P0 lungs six transgenic and six normal pups from one litter of the transgenic mosaic founder. (B, C, F, G) Scale bar=200 μm; (D, E, H, I) Scale bar=100 μm; (J,
K) Scale bar=15 μm.
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suggested that this founder did not express the transgene (data
not shown). However, the pups from the other mother showed an
abnormal lung phenotype. Of a total of 64 pups, 27 (42%) were
transgenic. Of these pups, 7 were born dead with a very
abnormal lung phenotype. There was no air in their lungs, which
suggests that they died within minutes of birth. The remainderwere sacrificed at P0 and all showed an abnormal lung
phenotype by histological analysis (Figs. 3F, H). When the
lungs of the surviving female were examined, they were normal.
From this we conclude that this transgenic female survived
because she was mosaic for the transgene.
The normal E18.5 embryonic lung contains many small distal
saccules or primitive alveoli, which are ready to open for
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expanding the alveoli (Figs. 3F, H). By contrast, transgenic lungs
contain few normal alveoli and are packed with numerous
epithelial cells (Figs 3C, E, G, I). To assess the level of transgenic
expression, we carried out microarray of lungs from one litter
(six transgenic and six normal pups) born to the mosaic
transgenic mother. All six miRNAs were clearly up-regulated
(Fig. 3L). Among cluster members, miR-17-5p and miR-20a are
up-regulated by about 5 fold, while the increases in miR-18,
miR-19a, miR-19b and miR-92 appear less. Considering that
we extracted the RNA from the whole lung lobe, the actual
increase of expression in epithelial cells is likely to be higher
than the value from the array. Although these pups all inherit the
same transgene, the level of expression of the cluster still varies
between individuals (Figure S3).
In situ hybridization confirmed the over-expression of
miRNAs in the transgenic lungs. MiR-17-5p is hardly detected
in the normal P0 lung (Fig. 3J), while in the transgenic lung, a
strong signal was observed in the epithelial cells. Significantly,
the miRNA appears to be concentrated in the apical cytoplasm
(Fig. 3K), as seen with the endogenous miRNAs at E11.5 and
E12.5.
Elevated proliferation of epithelial cells in transgenic lungs
To address whether the hypercellularity of the transgenic lung
involves epithelial cells, we carried out immunohistochemistry
with antibody to Nkx2.1, which marks all lung epithelial cells.
The transgenic lung has a significant higher percentage of Nkx
2.1 positive cells than the wild type (Figs. 4A, B).
To look at cell proliferation, we injected BrdU to the pregnant
mother at E18.5 and collected the embryos 1 h later. WhenFig. 4. Elevated number and proliferation of epithelial cells in the transgenic
lungs. (A, B) Nkx 2.1 (Titf1) immunostaining. (C, D) BrdU immunostaining.
The percentage of BrdU and Nkx 2.1 positive cells in the total cells of the lung
are shown in the top left corner of each diagram. Scale bars=50 μm.sections of a lung with a strong phenotype were analyzed the
percentage of total cells that were BrdU labeled was about 4-fold
higher than in the lung of a control, non-transgenic littermate
(Figs. 4C, D). Significantly, no cell death was observed by
cleaved caspase 3 staining in either transgenic or normal lungs
(data not shown). Control samples (E13.5 normal digits) exa-
mined at the same time ensured that apoptotic cells would have
been detected.
Epithelial cell differentiation in transgenic lungs
We used immunohistochemistry to examine P0 transgenic
lungs for differentiation of proximal and distal epithelial cells.
The proximal airways (intralobular bronchi and bronchioles) of
transgenic lungs contain Clara cells (positive for Scgb1a1/
CC10), ciliated cells (positive forβ-tubulin) and neuroendocrine
cells (positive for CGRP) (Figs. 5A–F). Significantly, lungs of
the dead pups, which had the most severe phenotype and did not
contain air, contain about three times more neuroendocrine cell
clusters compared with non-transgenic control pups collected
just before birth (Figs. 5F, M).
The distal region of transgenic lungs was packed with large
numbers of epithelial cells and showed few primitive alveoli.
These cells still maintain high levels of Sox9 (Fig. 5H). This
transcription factor is normally highly expressed in the distal
epithelial cells before E16.5 and is virtually undectectable in the
P0 lung (Okubo et al., 2005; Perl et al., 2005). The transgenic
distal epithelial cells also express high levels of Nmyc by
immunohistochemistry (Figs. 5I, J). This finding was confirmed
by microarray analysis of RNA extracted from transgenic and
control lungs which shows a ∼3 fold increase of Nmyc mRNA
(Fig. 5N). Furthermore, few cells in the transgenic distal lung
have strong Sp-C staining (Fig. 5L). Many of the distal cells
have weak signal, which is not easily distinguishable from the
background.
Analysis of lungs from E18.5 embryos also showed an
abnormal phenotype that varied between individuals. In some
transgenic embryos, expression of the differentiated cell marker,
Scgb1a1, was significantly reduced (Fig. 6E). In two, only a very
few weak positive cells were seen in the smaller bronchi and
bronchioles (Fig. 6F). Similar patterns were also seen for β-
tubulin staining (data not shown). The distal epithelial cells of
these transgenic lungs were Sox9 positive as seen in the trans-
genic P0 lungs (Figs. 6H, I). The difference between E18.5 and
P0 lungs suggests that not only is the proliferation of distal
progenitor cells enhanced by overexpression of miR-17-92, but
also the differentiation of proximal cells is delayed.
Evidence that miR-17-5p targets retinoblastoma-like 2
(Rbl2/p130)
To elucidate the possible mechanism causing the phenotype
of miR-17-92 transgenic lungs, we first used three well known
miRNA target programs (TargetScan, MiRanda and PicTar) to
predict 100 potential targets. Then we overlapped these 100
genes with 9497 genes downregulated in the transgenic lungs
derived from Affymetrix array. From this we obtained 65
Fig. 5. Epithelial progenitor cells persist in transgenic P0 lungs. (A, B) Scgb1a1/CC10, (C, D) β-tubulin, (E, F) CGRP, (G, H) Sox9, (I, J) Nmyc and (K, L) Sp-C were
detected by immunostaining. The black arrowheads in panels E and F mark the CGRP positive neuroendocrine cell clusters. White arrowheads mark the Sp-C positive
cells. (M) CGRP stained sections from the lungs of three dead pups and three prenatal embryos were counted for CGRP cluster numbers per millimeter luminal surface
of bronchus. Tg: 1.01±0.08/mm, N: 0.32±0.04/mm. Pb0.0002. (N) Increase of Nmyc mRNA was confirmed by microarray analysis. Three transgenic and three
normal lungs were tested in the Affymatrix array. Pb0.023. (A, B, D–J) Scale bars=50 um. (E, F) Scale bars=100 um. (K, L) Scale bars=5 μm. Tg: transgenic; N:
normal.
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for three reasons: First, Rbl2 was predicted with a high score by
three programs to have two miR-17-5p family target sites in the
3′UTR. Second, microarray analysis showed that the mRNA of
Rbl2 is down-regulated by about 10% in the transgenic lungs
compared with controls (Fig. 7D). Such a small downregulationis consistent with the behavior of mRNAs targeted by miRNAs
(Lim et al., 2005). Third, conditional deletion of all three genes of
the Rb family in the lung results in epithelial hyperplasia and an
increase in neuroendocrine clusters (Wikenheiser-Brokamp,
2004).We therefore linked the 3′UTR of Rbl2 to firefly luciferase
driven by the CMV promoter (Fig. 7A), and transfected this
Fig. 6. Differentiation of proximal epithelial cells is inhibited in transgenic embryos. (A–C) H&E staining of normal and two transgenic E18.5 lungs. (D–F) Scgb1a1/
CC10 immunostaining. (G–I) Sox9 immunostaining. Scale bars=50 μm.
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synthetic miR-17-5p precursor gave a decrease in the luciferase
signal by about 20% compared with a control miRNA precursor.
Mutation of the 3 nucleotides within the seed sequences of both
putative target sites in the 3′UTR abolished this downregulation
(Fig. 7C). To test whether the Rbl2 protein is regulated by miR-
17-5p in vivo, we performed immunohistochemistry of trans-
genic and normal lungs using antibody to Rbl2. This showed
that the level of Rbl2 in transgenic lung epithelial cells was
significantly reduced compared with non-transgenic controls
(Fig. 7H).
Discussion
In this paper we have identified a total of 198 miRNAs
differentially expressed during mouse lung development. We
have focused on the miR-17-92 cluster which is highly
expressed in both the epithelium and mesenchyme at E11.5
and declines gradually until it is barely detectable in the adult.
We hypothesized that high level of miR-17-92 cluster help to
maintain lung progenitor cells in a proliferative and undiffer-
entiated state. To test this hypothesis we generated transgenic
embryos which maintain this high expression level in the
epithelium throughout development. Both hyperproliferation
and diminished differentiation of distal epithelial cells were
observed in the transgenic lungs. Our finding that miR-17-5p
regulates the novel target, Rbl2, can partially explain the ab-
normal phenotype.MiRNA expression patterns in the lung
We found that miRNAs expressed in the developing lung fall
into several distinct subclasses. The majority, including miR-1
and Let-7 have highest expression in the adult. In other systems,
miR-1 has been shown to promote the differentiation and
maintain the differentiated state of cardiac and skeletal muscle
(Chen et al., 2006; Zhao et al., 2007), while Let-7 limits cell
growth in culture by targeting Ras (Johnson et al., 2005). It is
possible that in the lung these miRNAs have a similar function.
Significantly, Fgf signaling is important for the proliferation of
early lung progenitor epithelial cells (White et al., 2006) and the
regulation of FGF signaling mainly depends on the Ras/MAP
kinase pathway (Thisse and Thisse, 2005). So the low level of
Let-7 may facilitate high proliferation of lung progenitors in
early development, while the adult lung needs a high level of
Let-7 to slow down cell growth by targeting Ras. Loss of Let-
7 could help to elevate levels of Ras in lung cancer (Johnson
et al., 2005).
MiR-17-92 cluster expression
Among the miRNAs most highly expressed in the embryonic
lung were some (but not all) members of the miR-17-92 cluster.
This cluster encodes seven miRNAs within a 1 kb region and is
believed to be transcribed as one primary transcript. However,
both the microarray and microRNA cloning data show that the
expression level of individual cluster members varies, as
Fig. 7. Evidence that the 3′UTR of Rbl2 is targeted by miR-17-5p. (A) Schematic diagram of luciferase assay. 676 bp of Rbl2 3′UTR containing two predicted target
sites were cloned into the 3′ end of the firefly luciferase gene. (B) Positive control assay was performed using a sensor construct, s17, in which three perfect miR-17-5p
anti-sense fragments were cloned to the 3′end of firefly luciferase. n=3. The data from the control wells, which have the control miRNA (miR-Con), is normalized to 1.
(C) Rbl2 and Rbl2M 3′UTRwere tested in the luciferase assay. Rbl2M is the Rbl2 3′UTR fragment with 3 point mutations in each predicted target site. Firefly luciferase
reporter construct, renilla luciferase internal control vector and miRNAwere co-transfected to Hela cells. Pb0.002, n=9. (D) Rbl2mRNA level is slightly decreased in
transgenic lungs by microarray analysis. Two probes, Rbl2-1 and Rbl2-2, show similar ∼10% down-regulation in transgenic lungs. Three transgenic and three normal
P0 lung RNA samples were tested in the array. (E) Section through normal P0 lung interlobular airway. DIC image. (F) Immunofluorescence image using antibody to
Rbl2. The white arrowheads mark the epithelial cells expressing high levels of the protein in the nuclear and perinuclear locations. (G) Section through transgenic P0
lung airway. (H) Immunofluorescence image of the same section of panel G. Note lower levels of Rbl2 protein. Tg: transgenic; N: normal. Scale bar: 5 μm.
450 Y. Lu et al. / Developmental Biology 310 (2007) 442–453reported previously (Mineno et al., 2006). Differences in the
efficiency of post-transcriptional processing steps, mediated by
Drosha (Han et al., 2006), Exportin5 and Dicer (Lund and
Dahlberg, 2006), may account for this. However, it is still
difficult to explain why the abundance of miRNAs within the
cluster does not change co-ordinately between E11.5 and E17.5.
One possibility is that unknown processing mechanisms exist
that affect some members of the cluster but not others. This
hypothesis is supported by evidences for post-transcriptionalregulation of some miRNAs (Obernosterer et al., 2006;
Thomson et al., 2006; Wulczyn et al., 2007).
Relationship between miR-17-92 cluster expression and Nmyc
function in the developing lung
The miR-17-92 cluster was recently reported to be up-
regulated by the proto-oncogene Myc (Dews et al., 2006;
O'Donnell et al., 2005). Myc is a member of proto-oncogene
451Y. Lu et al. / Developmental Biology 310 (2007) 442–453family (Myc, Lmyc and Nmyc), which encodes basic helix–
loop–helix leucine zipper (bHLHz) proteins. One gene regulated
by Myc is E2f1, which is targeted by miR-17-5p and miR-20a.
Since E2f1 can also induce Myc expression (Matsumura et al.,
2003), it was suggested that the negative regulation of E2f1 by
miR-17-5p and miR-20a could dampen Myc-E2f1 reciprocal
activation (O'Donnell et al., 2005).
In the lung, Nmyc is specifically expressed in the epithelium,
while Myc is transcribed only in the mesenchyme. Over-
expression of Nmyc in the lung epithelium under the control of
human Sftpc regulatory elements caused elevated cell prolifera-
tion and inhibition of differentiation, with a phenotype very
similar to the phenotype of miR-17-92 cluster transgenic mice
(Okubo et al., 2005). So it was surprising that no significant up-
regulation of the miR-17-92 cluster was observed in the Nmy-
cEGFP transgenic lungs (Figure S4) despite the structural and
functional similarity between Myc and Nmyc. On the contrary,
levels of Nmyc are still high in Sftpc-miR-17-92 transgenic
lungs. We do not know whether the high level of Nmyc is due to
the large number of undifferentiated, Nmyc expressing epithelial
cells or to higher Nmyc expression per cell, or both. At least, it
suggests that high levels of the miR-17-92 cluster do not
negatively regulate Nmyc expression. This conclusion is
supported by evidence of augmentation of Myc-induced tumor
formation by co-over-expression of the miR-17-92 cluster
(Dews et al., 2006; He et al., 2005).
Possible mechanisms underlying the abnormal cell
proliferation and differentiation phenotype of transgenic lungs
Up to now, several genes have been identified as targets of
members of the miR-17-92 cluster by in vitro assays and
therefore need to be considered as candidate targets in the
developing lung. These include E2f1 (targeted by miR-17-5p/
20a), Pten (targeted by miR19), Ncoa3 (targeted by miR-17-
5p), Thbs1 (thrombospondin, targeted by miR19) and Ctgf
(connective tissue growth factor, targeted by miR-18) (Dews et
al., 2006; Hossain et al., 2006; Lewis et al., 2003; O'Donnell
et al., 2005). Among them, Ctgf is not apparently expressed in
the embryonic lung (Ivkovic et al., 2003) so it is not
considered further here. Of the remaining candidates, Ncoa3,
which encodes nuclear receptor co-activator 3, is amplified in
several cancers and acts as a proto-oncogene (Torres-Arzayus
et al., 2004). Ncoa3 null mutant mice are smaller than normal
and cells derived from mutant embryos show decreased
proliferation in response to insulin-like growth factor 1
(Wang et al., 2000). It therefore appears unlikely that down-
regulation of this protein would be a major cause underlying
the hyperproliferative phenotype reported here in miR-17-92
transgenic lungs.
Another potential target, E2f1, encodes a transcription factor
that promotes cell proliferation by transactivating genes required
for G1 to S transition (DeGregori et al., 1997; Johnson et al.,
1993). Deceased levels of E2f1 results in reduced apoptosis
(Field et al., 1996; Holmberg et al., 1998). Since neither the
normal developing lung nor transgenic lungs show evidence of
apoptosis, it is unlikely that miR-17-92 functions to promoteexpansion of the progenitor cells through inhibition of apoptosis
by downregulating E2f1.
Pten is a well known tumor suppressor gene that normally
restricts cell proliferation. Embryos lacking Pten die before
E10.5, while heterozygous mutant mice show increased tumor
incidence or hyperplasia in many tissues, including the
mammary gland, prostate and lymphoid system (Di Cristofano
et al., 1998; Freeman et al., 2006). Although a lung phenotype
was not reported in these heterozygotes, it is possible that
downregulation of Pten could contribute to the abnormal
phenotype seen here. Microarray analysis showed the Pten
mRNA level is downregulated by 20–30% in the transgenic
lungs (Table S1).
Thbs1 is an extracellular calcium binding protein with
multiple functions (Adams and Lawler, 2004). At E11.5,
Thbs1 mRNA is detected in distal epithelial cells (Liu and
Hogan, 2002) and Thbs1 protein is localized to the basal lamina
of both the embryonic and adult lung epithelium (O'Shea and
Dixit, 1988;Wight et al., 1985). In addition, Thbs1 is secreted by
alveolar macrophages and type II cells (Sage et al., 1983;
Yehualaeshet et al., 1999). Mice homozygous null for Thbs1
have hyperplasia in many tissues, including lung bronchial
epithelium (Crawford et al., 1998). However, this phenotype
may in large part be secondary to strong inflammation (Lawler
et al., 1998). It is therefore unclear whether down regulation of
the gene during lung development affects proliferation and
differentiation.
Here, we provide evidence that another important tumor
suppressor, Rbl2, is a target of miR-17-5p. Rbl2 belongs to the
Rb pocket protein family, which also contains Rb and Rbl1/
p107. All three members share extensive structural homology
and can inhibit E2f responsive promoters (Classon and Dyson,
2001). Rbl1 and Rbl2 can at least partially compensate for loss
of Rb function in vivo (Lipinski and Jacks, 1999). Studies
using both in situ hybridization and Northern blot have shown
that expression of Rbl2 increases during late embryonic
development and are maintained at relatively high levels in
the adult lung (Chen et al., 1996; Jiang et al., 1997; Pertile et
al., 1995). In addition, Rbl2 mRNA is transcribed in both
endoderm and mesoderm of the lung (Jiang et al., 1997). Our
immunohistochemistry data shows that Rbl2 protein more
abundant in non-transgenic epithelial cells compared to
transgenic (Figs. 7E–H). Taken together, all these observations
support Rbl2 is a direct target of miR-17-5p during normal lung
development.
Recently, pocket proteins have been shown to inhibit
neuroendocrine cell fate in the lung. Conditional deletion of
Rb or the whole Rb family, including Rbl2, leads to epithelial
cell hyperplasia and to an increase in both the number and size of
neuroendocrine clusters (Wikenheiser-Brokamp, 2004). Loss of
RBL2 gene is correlated with small cell lung cancer (Baldi et al.,
1996; Helin et al., 1997; Xue Jun et al., 2003), which is
considered to have a neuroendocrine cell origin. A significant
increase in neuroendocrine cell clusters is also observed in our
miR-17-92 transgenic P0 lungs, which supports the idea that
pocket proteins could bemiRNA targets. Although the whole Rb
family has been predicted to be targeted by miR-17-5p, only the
452 Y. Lu et al. / Developmental Biology 310 (2007) 442–453highest scored Rbl2 showed significant down-regulation in our
luciferase assay (data not shown). Whether knocking down Rbl2
alone can also lead to hypercellularity of neuroendocrine cells is
unclear, since no obvious phenotype has been reported in Rbl2
null mutant mice (Cobrinik et al., 1996).
In conclusion, we cannot expect to explain the phenotype of
Spc-miR-17-92 transgenic lungs by any single target gene and
there are likely more targets which have not yet been discovered.
To address which target or targets are most important for the
regulation of progenitor cell proliferation and differentiation
during lung development is a topic for future research.
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